title: [Conservative treatment in male urinary incontinence].
abstract: Prevalence, pathophysiology, diagnostic and therapeutic approaches of urinary incontinence are well studied in women; however, studies on male urinary incontinence focus on incontinence following surgery of the bladder or prostate, predominantly incontinence after radical prostatectomy. Aging men suffer from incontinence, most frequently urge incontinence (overactive bladder, OAB), nearly as often as women do.The domain of conservative therapy of urinary stress incontinence in men is pelvic floor training. It remains unclear whether biofeedback procedures, electrostimulation therapy, or magnetic stimulation therapy can enhance pelvic floor training. There are data suggesting that an off-label therapy with Duloxetin®, a selective serotonin-noradrenaline reuptake inhibitor (SSNRI), improves urinary incontinence following radical prostatectomy. Antimuscarinic agents in combination with bladder training have been proven as safe and effective treatment in men with OAB. Data, however, suggest that men with OAB are far less frequently treated than women.
authors.affiliation: Neuro-Urologie, Universitätsklinikum, Rheinische Friedrich-Wilhelms Universität Bonn, Sigmund-Freud-Straße 25, 53105, Bonn, Deutschland, ruth.kirschner-hermanns@ukb.uni-bonn.de.
authors.forename: R
authors.initials: R
authors.lastname: Kirschner-Hermanns
authors.forename: R
authors.initials: R
authors.lastname: Anding
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use; D000068736:Duloxetine Hydrochloride; D004599:Electric Stimulation Therapy / Q000379:methods*; D005081:Exercise Therapy / Q000379:methods*; D006801:Humans; D008297:Male; D054526:Men's Health; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D017773:Pelvic Floor; D011468:Prostatectomy / Q000009:adverse effects; D013876:Thiophenes / Q000627:therapeutic use*; D016896:Treatment Outcome; D014550:Urinary Incontinence, Stress / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy
chemical_list: D018759:Adrenergic Uptake Inhibitors; D018727:Muscarinic Antagonists; D013876:Thiophenes; D000068736:Duloxetine Hydrochloride